The Ranger system and the DFC technique are widely applicable to the mammalian cell cultures and microbial fermentations which are utilised in the biopharmacuetical sector.

Cell and Gene Therapy

We are working with a number of cell and gene therapy companies to develop processes using Ranger, particularly processes for autologous therapies, where the need for consistency in the rapid expansion of high viability and high cell densities are critical for patient outcomes. Ranger is equally capable of providing the solution for many of the acute scale up challenges faced by the industry for allogeneic product manufacture to help reduce costs and make cell and gene therapies commercially viable in the long term.


Case Studies